-
Mashup Score: 0FirstWord Pharma - 1 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
What happened to Palfozia? This story misses one major cause why Palfozia is not getting used by the allergy community. Allergists are using off label peanut preparations for oral immunotherapy instead of Palfozia. Nestlé mulls divesting Palforzia https://t.co/pMNbarSSID
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Nestlé mulls divesting Palforzia amid sluggish sales https://t.co/pMNbarBhk3 via @fwpharma
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Novartis weighing sale of ophthalmology, respiratory units: report | FirstWord Pharma https://t.co/lLSLCMiqLg
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Arcutis says atopic dermatitis cream roflumilast hits main goal in Phase III trial | FirstWord Pharma https://t.co/Ytk09bJGid
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Omicron subvariants resistant to key antibody treatments are increasing https://t.co/mkpZHe8cAD via @fwpharma
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
AstraZeneca's Fasenra produces mixed results in eosinophilic oesophagitis study | FirstWord Pharma https://t.co/Ifm8ghQhYc
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
FDA clears Sanofi, Regeneron's Dupixent for prurigo nodularis https://t.co/Xf0VtHikJz via @fwpharma
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
AstraZeneca, Amgen's Tezspire wins EU approval for severe asthma | FirstWord Pharma https://t.co/HRMLiY3YpB
-
-
Mashup Score: 0FirstWord Pharma - 2 year(s) agoSource: firstwordpharma.comCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Another one bites the dust. Allakos ends lirentelimab work in eosinophilic GI diseases after another mixed readout https://t.co/qKdkA0COzy via @fwpharma
-
Third Harmonic sinks after pulling plug on urticaria drug trial https://t.co/sLUf6UWCrN via @fwpharma